Voloridge Investment Management’s Kalaris Therapeutics, Inc. Common Stock KLRS Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-1,239	Closed	-$563K	–	1910
2021 Q2	$563K	Buy	+1,239	New	+$563K	﹤0.01%	1410